Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Investigação de Amostragem Venosa Adrenal da China (CHAMPION)

6 de novembro de 2026 atualizado por: Hui DONG, Chinese Academy of Medical Sciences, Fuwai Hospital

Investigação Chinesa de Amostragem Venosa Adrenal: Um Estudo Multicêntrico Nacional

Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Descrição detalhada

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, yet its optimal diagnostic and therapeutic strategies remain challenging. Adrenal venous sampling (AVS) is regarded as the gold standard for subtype differentiation; however, important clinical, technical, and methodological issues have not been systematically addressed. This study is designed to comprehensively evaluate AVS and its clinical implications, aiming to elucidate the relationship between AVS-guided diagnosis and management of PA and long-term clinical and biochemical outcomes, while refining AVS protocols, standardizing clinical practice, optimizing therapeutic decision-making, and ultimately improving patient management and prognosis.

Tipo de estudo

Observacional

Inscrição (Estimado)

5000

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • Anhui
      • Hefei, Anhui, China, 230036
        • Recrutamento
        • The first affiliated hospital of USTC
        • Contato:
        • Investigador principal:
          • Xiangyong Kong, PhD
    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100034
        • Recrutamento
        • Peking University First Hospital
        • Investigador principal:
          • Wei Ma, MD
        • Contato:
      • Beijing, Beijing Municipality, China, 100044
        • Recrutamento
        • Peking University People's Hospital
        • Contato:
        • Investigador principal:
          • Jing Liu, MD
      • Beijing, Beijing Municipality, China, 100029
        • Recrutamento
        • China-Japan Friendship Hospital
        • Investigador principal:
          • Wuqiang Che, MD
        • Contato:
      • Beijing, Beijing Municipality, China, 100022
        • Recrutamento
        • Chuiyangliu Hospital affiliated to Tsinghua University
        • Investigador principal:
          • Lin Pi, MD
        • Contato:
      • Beijing, Beijing Municipality, China, 100037
        • Recrutamento
        • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
        • Investigador principal:
          • Hui Dong, MD
        • Contato:
        • Contato:
      • Beijing, Beijing Municipality, China, 101100
        • Recrutamento
        • Beijing Luhe Hospital, Capital Medical University
        • Contato:
        • Investigador principal:
          • Dong Zhao, MD, PhD
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, China, 400000
        • Recrutamento
        • Chongqing University Central Hospital
        • Investigador principal:
          • Dongying Zhang, MD
        • Contato:
      • Chongqing, Chongqing Municipality, China, 401147
        • Recrutamento
        • Chongqing General Hospital
        • Investigador principal:
          • Rui He, MM
        • Contato:
      • Chongqing, Chongqing Municipality, China, 404100
        • Recrutamento
        • People's Hospital Affiliated to ChongqingThree Gorges Medical college
        • Investigador principal:
          • Xianhu Luo, MD
        • Contato:
    • Fujian
      • Fuzhou, Fujian, China, 0591-87982222
        • Recrutamento
        • First Affiliated Hospital, Fujian Medical University, Fuzhou, China,
        • Contato:
        • Investigador principal:
          • Feng Peng, MD
      • Xiamen, Fujian, China, 361016
        • Recrutamento
        • Cardiovascular Hospital Xiamen University
        • Investigador principal:
          • Tao Ye, MD
        • Contato:
    • Gansu
      • Lanzhou, Gansu, China, 730000
        • Recrutamento
        • Lanzhou University Second Hospital
        • Investigador principal:
          • Wei Liang, MD
        • Contato:
    • Guangdong
      • Foshan, Guangdong, China, 528211
        • Recrutamento
        • The Forth People's Hosptal of Nanhai District of Foshan City
        • Investigador principal:
          • Yayan Han, MD
        • Contato:
      • Guangzhou, Guangdong, China, 510080
        • Recrutamento
        • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
        • Investigador principal:
          • Yingqing Feng, MD
        • Contato:
          • Yingqing Feng, MD
          • Número de telefone: 13602863389
          • E-mail: fyq1819@163.com
      • Shenzhen, Guangdong, China, 518000
        • Recrutamento
        • Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
        • Contato:
        • Investigador principal:
          • Jianqiong Kong, MD
      • Shenzhen, Guangdong, China, 518112
        • Recrutamento
        • Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
        • Contato:
          • Zhenzhong Zheng, MD, PhD
          • Número de telefone: 0755-61222333
          • E-mail: greateful@163.com
        • Investigador principal:
          • Zhenzhong Zheng, MD, PhD
      • Shenzhen, Guangdong, China, 518116
        • Recrutamento
        • Shenzhen Dapeng New District Kuiyong People's Hospital
        • Investigador principal:
          • Tongqing Lu, MD
        • Contato:
    • Guangxi
      • Nanning, Guangxi, China, 530000
        • Recrutamento
        • The First Affiliated Hospital of Guangxi Medical University
        • Investigador principal:
          • Jiangnan Huang, MD
        • Contato:
      • Nanning, Guangxi, China, 530007
        • Recrutamento
        • The Second Affliated Hospital Of GuangXi Medical Univesity
        • Contato:
        • Investigador principal:
          • Houfa Ning, MM
      • Nanning, Guangxi, China, 547000
        • Recrutamento
        • Nanning Third People's Hospital
        • Contato:
          • Yongqi Xiao, MBBS
          • Número de telefone: 07713394390
        • Investigador principal:
          • Yongqi Xiao, MBBS
    • Guizhou
      • Guiyang, Guizhou, China, 550004
        • Recrutamento
        • The Affiliated Hospital of Guizhou Medical University
        • Contato:
        • Investigador principal:
          • Zhangrong Chen, MD
      • Guiyang, Guizhou, China, 550002
        • Recrutamento
        • Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.
        • Contato:
        • Investigador principal:
          • Fang Song, MD
      • Kaili, Guizhou, China, 556000
        • Recrutamento
        • The Second Affiliated Hospital Of Guizhou Medical University
        • Investigador principal:
          • Yumei Xiang, MD
        • Contato:
    • Hainan
      • Haikou, Hainan, China, 570311
        • Recrutamento
        • Hainan General Hospital, Department of Endocrinology
        • Contato:
        • Investigador principal:
          • Haiyu Zhang, MM
      • Hainan, Hainan, China, 570311
        • Recrutamento
        • Hainan General Hospital, Department of Cardiology
        • Contato:
        • Investigador principal:
          • Wang Liao, MD
    • Hebei
      • Tangshan, Hebei, China, 063000
        • Recrutamento
        • Tangshan hongci Hospital
        • Investigador principal:
          • Guijuan Zhang, MD
        • Contato:
    • Heilongjiang
      • Harbin, Heilongjiang, China, 150086
        • Recrutamento
        • The Second Affiliated Hospital of Harbin Medical University
        • Contato:
        • Investigador principal:
          • Shuo Zhang, MD
      • Harbin, Heilongjiang, China, 150001
        • Recrutamento
        • The First Affiliated Hospital of Harbin Medical University
        • Investigador principal:
          • Dechao Zhao, MD
        • Contato:
    • Henan
      • Kaifeng, Henan, China, 475002
        • Recrutamento
        • Kai Feng the Peoples Hospital
        • Contato:
        • Investigador principal:
          • Qingli Pan, MD
      • Zhengzhou, Henan, China, 450052
        • Recrutamento
        • The First Affiliated Hospital of Zhengzhou University
        • Contato:
        • Investigador principal:
          • Youyou Du, MD
      • Zhengzhou, Henan, China, 450003
        • Recrutamento
        • Henan Provincial People's Hospital
        • Investigador principal:
          • Min Liu, MD
        • Contato:
      • Zhengzhou, Henan, China, 450000
        • Recrutamento
        • Fuwai Central China Cardiovascular Hospital
        • Investigador principal:
          • Qiuping Zhao, PhD
        • Contato:
      • Zhengzhou, Henan, China, 450018
        • Recrutamento
        • Zhengzhou Yihe Hospital
        • Contato:
        • Investigador principal:
          • Liang An, MD
      • Zhengzhou, Henan, China, 450007
        • Recrutamento
        • Zhengzhou Central Hospital Affiliated to Zhengzhou University
        • Investigador principal:
          • Shuhua Yu, MM
        • Contato:
      • Zhoukou, Henan, China, 466000
        • Recrutamento
        • Zhoukou Central Hospital
        • Investigador principal:
          • Baogong Wang, MD
        • Contato:
    • Hubei
      • Wuhan, Hubei, China, 430060
        • Recrutamento
        • Renmin Hospital of Wuhan University
        • Contato:
        • Investigador principal:
          • Hongxin Xu, MD
      • Xiangyang, Hubei, China, 441021
        • Recrutamento
        • Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
        • Contato:
        • Investigador principal:
          • Qingan Li, MD
      • Yichang, Hubei, China, 43000
        • Recrutamento
        • Yichang Central People's Hospital
        • Investigador principal:
          • Yunbo Lv, MD
        • Contato:
    • Hunan
      • Zhuzhou, Hunan, China, 412000
        • Recrutamento
        • Zhuzhou Hospital Affiliated to Xiangya School of Medicine,Central South University
        • Contato:
          • Liang Tang, MBBS
          • Número de telefone: 0733-28561703
        • Investigador principal:
          • Liang Tang, MBBS
    • Jiangsu
      • Xuzhou, Jiangsu, China, 221009
        • Recrutamento
        • Xuzhou Central Hospital, Jiangsu
        • Contato:
        • Investigador principal:
          • Hongyun Ruan, MD
    • Jiangxi
      • Ganzhou, Jiangxi, China, 341000
        • Recrutamento
        • The First Affiliated Hospital of Gannan Medical University
        • Contato:
          • Jiayuan Ling, MD
          • Número de telefone: 18807972012
          • E-mail: 15803152@qq.com
        • Investigador principal:
          • Jiayuan Yuan, MD
      • Nanchang, Jiangxi, China, 330006
        • Recrutamento
        • Second Affiliated Hospital of Nanchang University
        • Contato:
        • Investigador principal:
          • Yifei Dong, MD, PhD
      • Nanchang, Jiangxi, China, 330038
        • Recrutamento
        • Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
        • Investigador principal:
          • Haohang Ruan, MBBS
        • Contato:
          • Haohang Ruan, MBBS
          • Número de telefone: 0791-87721036
    • Jilin
      • Changchun, Jilin, China, 130021
        • Recrutamento
        • The First Hospital of Jilin University
        • Contato:
        • Investigador principal:
          • Wei Zhao, MD
      • Changchun, Jilin, China, 130051
        • Recrutamento
        • Jilin Province FAW General Hospital
        • Investigador principal:
          • Wenhai Wang, MM
        • Contato:
    • Liaoning
      • Dalian, Liaoning, China, 116001
        • Recrutamento
        • Affilated Zhongshan Hospital of Dalian University
        • Contato:
        • Investigador principal:
          • Minglian Gong, MD
      • Dalian, Liaoning, China, 116011
        • Recrutamento
        • Frist Aiffiliated Hospital of Dalian Medical University
        • Investigador principal:
          • Yinong Jiang, MD
        • Contato:
      • Dalian, Liaoning, China, 116027
        • Recrutamento
        • The second hospital of Dalian Medical University
        • Contato:
        • Investigador principal:
          • Nan Niu, MD
    • Neimenggu
      • Ulanhot, Neimenggu, China, 137400
        • Recrutamento
        • Inner Mongolia Xing'an League People's Hospital
        • Contato:
        • Investigador principal:
          • Tao Guo, MM
    • Ningxia
      • Yinchuan, Ningxia, China, 750000
        • Recrutamento
        • The First People's Hospital of Yinchuan
        • Contato:
        • Investigador principal:
          • Fang Chen, PhD
    • Qinghai
      • Xining, Qinghai, China, 810001
        • Recrutamento
        • Qinghai University Affiliated Hospital
        • Contato:
        • Investigador principal:
          • Ming Ren, MM
      • Xining, Qinghai, China, 810000
        • Recrutamento
        • Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
        • Contato:
        • Investigador principal:
          • Xiaozhou Wang, MD
    • Shandong
      • Jinan, Shandong, China, 250012
        • Recrutamento
        • Qilu Hospital of Shandong University
        • Investigador principal:
          • Peili Bu, MD
        • Contato:
      • Jinan, Shandong, China, 250013
        • Recrutamento
        • Central Hospital Affiliated to Shandong First Medical University
        • Contato:
        • Investigador principal:
          • Rui Xu, MD, PhD
      • Jinan, Shandong, China, 250000
        • Recrutamento
        • the Second Hospital, Cheeloo College of Medicine, Shandong University
        • Contato:
        • Investigador principal:
          • Qinghai Wang, MD
      • Liaocheng, Shandong, China, 252200
        • Recrutamento
        • People's Hospital of Donga County, Shandong Province
        • Investigador principal:
          • Xiaoli Wang, MD
        • Contato:
      • Qingdao, Shandong, China, 266000
        • Recrutamento
        • Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
        • Contato:
        • Investigador principal:
          • Nan Jia, MD
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200025
        • Recrutamento
        • Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        • Contato:
        • Investigador principal:
          • Jianzhong Xu, MD, PhD
      • Shanghai, Shanghai Municipality, China, 200062
        • Recrutamento
        • Shanghai Putuo District Central Hospital
        • Investigador principal:
          • Zongjun Liu, MD
        • Contato:
      • Shanghai, Shanghai Municipality, China, 200080
        • Recrutamento
        • Shanghai General Hospital ( originally named Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
        • Contato:
        • Investigador principal:
          • Zhi Zhang, MD
    • Shanxi
      • Taiyuan, Shanxi, China, 030001
        • Recrutamento
        • the second hospital of ShanXi medical unversity
        • Investigador principal:
          • Bin Yang, MD
        • Contato:
      • Xi’an, Shanxi, China, 710018
        • Recrutamento
        • Xi'an People's Hospital
        • Contato:
        • Investigador principal:
          • Kang Cheng, MD, PhD
    • Sichuan
      • Chengdu, Sichuan, China, 611130
        • Recrutamento
        • Chengdu Fifth People's Hospital
        • Investigador principal:
          • Mingjian Lang, MD
        • Contato:
          • Mingjian Lang
          • Número de telefone: (028) 8271 0681
          • E-mail: zcl628@163.com
      • Chengdu, Sichuan, China, 610500
        • Recrutamento
        • The First Affiliated Hospital of Chengdu Medical College
        • Investigador principal:
          • Peijian Wang, MD
        • Contato:
      • Chengdu, Sichuan, China, 610031
        • Recrutamento
        • The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
        • Investigador principal:
          • Zhen Zhang, MD
        • Contato:
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, China, 300052
        • Recrutamento
        • Tianjin Medical University General Hospital
        • Investigador principal:
          • Dianxun Fu, MD
        • Contato:
      • Tianjin, Tianjin Municipality, China, 300211
        • Recrutamento
        • The Second Hospital of Tianjin Medical University
        • Investigador principal:
          • Changle Liu, MD
        • Contato:
      • Tianjin, Tianjin Municipality, China, 300457
        • Recrutamento
        • TEDA International Cardiovascular Hospital
        • Contato:
        • Investigador principal:
          • Weiqiang Wang, MM
    • Tibet
      • Chamdo, Tibet, China, 854000
        • Recrutamento
        • Changdu People's Hospital of Tibet
        • Contato:
          • Rui Xiang, MD
          • Número de telefone: 0895-4821745
        • Investigador principal:
          • Rui Xiang, MD
    • Xinjiang
      • Yining, Xinjiang, China, 835000
        • Recrutamento
        • Yili Kazak Autonomous Prefecture Friendship Hospital
        • Contato:
        • Investigador principal:
          • Wei Li, MBBS
      • Ürümqi, Xinjiang, China, 830001
        • Recrutamento
        • Xinjiang Uygur Autonomous Region People's Hospital
        • Contato:
        • Investigador principal:
          • Guoliang Wang, PhD
    • Yunnan
      • Kunming, Yunnan, China, 650031
        • Recrutamento
        • The First Affiliated Hospital of Kunming Medical University
        • Contato:
        • Investigador principal:
          • Lihua Zhang, PhD
      • Kunming, Yunnan, China, 650102
        • Recrutamento
        • Fuwai Yunnan Cardiovascular Hospital
        • Investigador principal:
          • Zihong Guo, MD
        • Contato:
      • Kunming, Yunnan, China, 650051
        • Recrutamento
        • Yan'an Affiliated Hospital of Kunming Medical University
        • Contato:
        • Investigador principal:
          • Yan He, MD
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310000
        • Recrutamento
        • Zhejiang Hospital
        • Investigador principal:
          • Yimin Tang, MD
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

All patients with confirmed primary aldosteronism underwent adrenal venous sampling.

Descrição

Inclusion Criteria:

  1. Patients with confirmed primary aldosteronism;
  2. Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism.

Exclusion Criteria:

  1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  2. An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  3. Patients who refuse adrenalectomy;
  4. Suspected of having an adrenocortical carcinoma;
  5. Allergy to contrast agent;
  6. Pregnant, nursing, or planning to become pregnant

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: COHORT
  • Perspectivas de Tempo: OTHER

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Adrenal Venous Sampling

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Major adverse cardiovascular events (MACE) at 1-year follow-up
Prazo: 1 year after AVS procedure

Incidence of major adverse cardiovascular events (MACE) at 1-year follow-up, including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

1 year after AVS procedure

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
The success rate of left adrenal venous sampling
Prazo: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of right adrenal venous sampling
Prazo: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of bilateral adrenal venous sampling
Prazo: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
Selection of intraoperative catheter
Prazo: At AVS procedure

Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach

At AVS procedure
Time of the procedure
Prazo: At AVS procedure

Time of the procedure

At AVS procedure
Time of fluoroscopy
Prazo: At AVS procedure

Time of fluoroscopy

At AVS procedure
The contrast agent dosage
Prazo: At AVS procedure

The contrast agent dosage

At AVS procedure
the incidence of complications
Prazo: 1 week after AVS procedure

Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc)

1 week after AVS procedure
the cost of the procedure
Prazo: At AVS procedure

the cost of the procedure

At AVS procedure
Change in 24-hour ambulatory systolic blood pressure
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average systolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) between baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in 24-hour ambulatory diastolic blood pressure
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average diastolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) bewteen baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office systolic blood pressure
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in systolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office diastolic blood pressure
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in diastolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in antihypertensive medication burden
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in the number and/or dosage of antihypertensive medications taken by patients between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in urinary albumin-to-creatinine ratio (UACR)
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in urinary albumin-to-creatinine ratio measured at baseline and at each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in left ventricular mass index (LVMI)
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in left ventricular mass index, as assessed by echocardiography, from baseline to each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in pulse wave velocity (PWV) from baseline
Prazo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in pulse wave velocity measured between baseline and each follow-up time point。

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Clinical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Prazo: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Clinical outcomes will be assessed at each follow-up visit afteradrenal surgery according to the PASO consensus criteria. Outcomes will be categorized as:

(1)Complete clinical success: normal blood pressure without the need for any antihypertensive medication. (2)Partial clinical success: improvement in blood pressure and/or a reduction in the number or dosage of antihypertensive medications. (3)Absent clinical success: no improvement in blood pressure or antihypertensive medication burden.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Biochemical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Prazo: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Biochemical outcomes will be assessed at each follow-up visit after adrenal surgery according to the PASO consensus classification. Outcomes will be categorized as:(1)Complete biochemical success: normal serum potassium levels and a normalized aldosterone-to-renin ratio (ARR) without the need for potassium supplementation.(2)Partial biochemical success: improvement in biochemical parameters without full normalization.(3)Absent biochemical success: no improvement in biochemical markers compared to baseline.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Major adverse cardiovascular events (MACE)
Prazo: At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Incidence of major adverse cardiovascular events (MACE), including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Hui Dong, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de dezembro de 2025

Conclusão Primária (Estimado)

31 de agosto de 2029

Conclusão do estudo (Estimado)

31 de agosto de 2029

Datas de inscrição no estudo

Enviado pela primeira vez

19 de novembro de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de novembro de 2025

Primeira postagem (Real)

26 de novembro de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

10 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

6 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2024-2484

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .